Dementia News and Research

Latest Dementia News and Research

Studies advance the understanding of sensory disconnection during sleep and anesthesia

During sleep and under anesthesia, we rarely respond to such external stimuli as sounds even though our brains remain highly active.

28 May 2020

Faulty ApoE4 gene increases risk for Alzheimer’s and for COVID-19

It has not been clear whether dementia worsens the infection or if it has resulted from the patient's old age and the severity of care home outbreaks. Now, a new study sheds light on the reason why people with dementia are at a high risk of developing severe disease caused by the coronavirus disease.

27 May 2020

Is air pollution a risk factor for COVID-19 infection?

The COVID-19 pandemic began at the very end of 2019 in Wuhan city, Hubei province, China. However, its spread soon began to threaten the health of the whole country and then of the world, leading to nearly 5.7 million cases and over 355,000 dead as of today. A new study, published on the preprint server medRxiv* in May 2020, explores the effects of air pollution on COVID-19 infections in China.

27 May 2020

Research provides new evidence for potential blood-based biomarker for Alzheimer's

A potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study.

27 May 2020

Early surgery improves outcome and survival in patients with hydrocephalus

Early surgery improved both outcome and survival in patients with the neurological condition hydrocephalus, while mortality was higher in those who had to wait, according to a thesis from the University of Gothenburg, Sweden.

26 May 2020

Genes associated with dementia doubles the risk of developing severe COVID-19

Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.

26 May 2020

New design strategy marks a potential advance in the fight against Alzheimer's disease

Researchers have found a way to design an antibody that can identify the toxic particles that destroy healthy brain cells - a potential advance in the fight against Alzheimer's disease.

26 May 2020

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

With many hundreds of thousands of deaths due to the current COVID-19 pandemic, there is a rush to find an effective vaccine or drug against the virus. A new study on the preprint server medRxiv* in May 2020 shows that the use of some biologically plausible drugs may be counterproductive, and care should be taken when trying out unproven therapies.

22 May 2020

Lowering blood pressure reduces risk of developing dementia, research shows

Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.

21 May 2020

Exercise boosts blood flow into brain regions associated with memory

Scientists have collected plenty of evidence linking exercise to brain health, with some research suggesting fitness may even improve memory. But what happens during exercise to trigger these benefits?

20 May 2020

A new treatment option for activating cellular defenses against neurodegenerative disease

Talk about motherly instincts: Biologists at the University of Iowa have learned that female roundworms can alert their future offspring of dangers they will encounter when born, and the mothers pass on these warnings even before the offspring have been conceived.

19 May 2020

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions.

18 May 2020

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

The Critical Path Institute and Provention Bio, Inc. are proud to announce their collaboration to significantly improve the scientific community's insight into type 1 diabetes through Provention's contribution of data from the Phase III Protégé study of teplizumab to the T1D Trial Outcome Measures Initiative integrated database.

13 May 2020

Simple molecular reagents to fight against neurodegenerative disorders

Sometimes the most complex problems actually have very simple solutions. A group of South Korean researchers reported an efficient and effective redox-based strategy for incorporating multiple functions into simple molecular reagents against neurodegenerative disorders.

11 May 2020

Exposure to racial residential segregation associated with worse cognitive performance in mid-life

A study at Columbia University Mailman School of Public Health found that black subjects who were exposed to highly segregated neighborhoods in young adulthood exhibited worse performance in cognitive skills in mid-life.

9 May 2020

Study shows how long-term use of acid suppressants could increase risk of dementia

Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.

8 May 2020

Vitamin D could improve outcomes in COVID-19

A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.

7 May 2020

New app to be developed to protect carers, support workers during COVID-19 pandemic

Three University of Stirling projects will play a key role in safeguarding carers and support workers during the COVID-19 pandemic - and assessing the impact the experience has on them.

7 May 2020

Researchers identify changes in the aging brain related to blood circulation

Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have identified changes in the aging brain related to blood circulation.

7 May 2020

Study examines the link between flavenoid-rich foods and risk of Alzheimer’s disease

Older adults who consumed small amounts of flavonoid-rich foods, such as berries, apples and tea, were two to four times more likely to develop Alzheimer's disease and related dementias over 20 years compared with people whose intake was higher, according to a new study led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University.

6 May 2020

Dementia News and Research

Latest Dementia News and Research

Studies advance the understanding of sensory disconnection during sleep and anesthesia

Faulty ApoE4 gene increases risk for Alzheimer’s and for COVID-19

Is air pollution a risk factor for COVID-19 infection?

Research provides new evidence for potential blood-based biomarker for Alzheimer's

Early surgery improves outcome and survival in patients with hydrocephalus

Genes associated with dementia doubles the risk of developing severe COVID-19

New design strategy marks a potential advance in the fight against Alzheimer's disease

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

Lowering blood pressure reduces risk of developing dementia, research shows

Exercise boosts blood flow into brain regions associated with memory

A new treatment option for activating cellular defenses against neurodegenerative disease

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

Simple molecular reagents to fight against neurodegenerative disorders

Exposure to racial residential segregation associated with worse cognitive performance in mid-life

Study shows how long-term use of acid suppressants could increase risk of dementia

Vitamin D could improve outcomes in COVID-19

New app to be developed to protect carers, support workers during COVID-19 pandemic

Researchers identify changes in the aging brain related to blood circulation

Study examines the link between flavenoid-rich foods and risk of Alzheimer’s disease

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in